Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 95, Issue 1-5, 2005, Pages 105-111

  Kristensen, Vessela Nedelcheva ^a   Sørlie, Therese ^a   Geisler, Jürgen ^b   Yoshimura, Noriko ^c   Linegjærde, Ole Christian ^d   Glad, Ingrid ^d   Frigessi, Arnoldo ^d   Harada, Nobuhiro ^c   Lønning, Per Eystein ^b   Børresen Dale, Anne Lise ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Aromatase inhibitor; Competitive RT PCR; Metabolism; Microarray analysis; mRNA expression; Therapy response

Indexed keywords

ACYLTRANSFERASE; ANASTROZOLE; APOLIPOPROTEIN D; AROMATASE INHIBITOR; CADHERIN; ENZYME; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR; ESTRONE; ESTRONE SULFATE; HORMONE RECEPTOR; KERATIN; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 3;

AGED; BIOCHEMISTRY; BREAST CANCER; CANCER LOCALIZATION; CELL CYCLE; CELL GROWTH; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENETIC CODE; GENOMICS; HUMAN; HUMAN TISSUE; METABOLISM; PILOT STUDY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; NITRILES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRIAZOLES; TUMOR MARKERS, BIOLOGICAL;

EID: 23744455456     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.04.028     Document Type: Conference Paper

References (21)

1. P.-E. Lønning Pharmacology of new aromatase inhibitors Breast 5 1996 202 208
2. Lønning P.-E., Comparison between aromatase inhibitors in sequential use. J. Steroid Biochem. Mol. Biol., in press.
3. J. Geisler, N. King, M. Dowsett, L. Ottestad, S. Lundgren, P. Walton, P.O. Kormeset, and P.E. Lønning Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatization and plasma estrogen levels in postmenopausal women with breast cancer Br. J. Cancer 74 1996 1286 1291
4. J. Geisler, S. Detre, H. Berntsen, L. Ottestad, B. Lindtjørn, M. Dowsett, and P.E. Lønning Influence of neoadjuvant anastrozole (Arimidex) on intratumoral Estrrogen lelves and proliferation markers in patients with locally advanced breast cancer Clin. Cancer Res. 7 2001 1230 1236
5. J.M. Dixon, L. Renshaw, C. Bellamy, M. Stuart, G. Hoctin-Boes, and W.R. Miller The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancena randomized, double-blind, single center study Clin. Cancer Res. 6 2000 2229 2235
6. J. Geisler, and P.-E. Lønning Resistance to endocrine therapy of breast cancer: recent advances and tomorrow's challenges Clin. Breast Cancer 1 2001 297 308
7. R.I. Nicholson, and J.M.W. Gee Oestrogen and growth factor cross talk and endocrine insensitivity and acquired resistance in breast cancer Br. J. Cancer 52 2000 5011 5013
8. W.R. Miller, P. Mullen, J. Telford, and J.M. Dixon Clinical importance of intratumoral aromatase Breast Cancer Res. Treat. 49 1998 S27 S32
9. M. Fille, J.D. Shanley, and J. Aslanzadeh Quantitative RT-PCR using a PCR-generated competitive internal standard Biotechniques 23 1977 34 36
10. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
11. T. Sorlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc. Natl. Acad. Sci. U.S.A. 98 2001 10869 10874
12. T. Sorlie, R. Tibshirani, and J. Parker Repeated observation of breast tumor subtypes in independent gene expression data sets Proc. Natl. Acad. Sci. U.S.A. 100 2003 8418 8423
13. R.A. Johnson, and D.W. Wichern Applied multivariate statistical analysis Stat. Med. 30 2001 2205 2211
14. M. Aitkin A general maximum likelihood analysis of variance components in generalized linear models Biometrics 55 1999 117 128
15. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc. Natl. Acad. Sci. U.S.A. 98 2001 5116 5121
16. R. Tibshirani, T. Hastie, B. Narasimhan, and G. Chu Diagnosis of multiple cancer types by shrunken centroids of gene expression Proc. Natl. Acad. Sci. U.S.A. 99 2002 6567 6572
17. H. Zhao, A. Langerod, and Y. Ji Different gene expression patterns in invasive lobular and ductal carcinomas of the breast Mol. Biol. Cell 6 2004 2523 2536
18. N. Yoshumura, N. Haxada, I. Bukholm, R. Karesen, A.L. Borresen-Dale, and V.N. Kristensen Intratumoural mRNA expression of genes from the estradiol metabolic pathway and clinical and histopathological parameters of breast cancer Breast Cancer Res. 6 2004 46 55
19. V.N. Kristensen, T. Sørlie, J. Geisler, A. Langerød, N. Yoshimura, R. Kåresen, N. Harada, P.E. Lønning, A.-L. Børresen-Dale, Microarray expression profiling of breast cancer in relation to ER status and estrogen-metabolizing enzymes: clinical implications, Clin. Cancer Res., in press.
20. T. Utsumi, N. Yoshimura, M. Maruta, S. Takeuchi, J. Ando, Y. Mizoguchi, and N. Harada Correlation of cyclin D1 mRNA levels with clinico-pathological parameters and clinical outcome in human breast carcinomas Int. J. Cancer 89 2000 39 43
21. P. Roger, M.E. Sahla, S. Makela, J.A. Gustafsson, P. Baldet, and H. Rochefort Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors Cancer Res. 61 2001 2537 2541